Home
About
Overview
Sharing Data
ORCID
Help
History (28)
American Heart Association/american College of Cardiology Foundation/heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention.
DC2 and KCP2 mediate the interaction between the oligosaccharyltransferase and the ER translocon.
RNA-mediated symmetry breaking enables singular olfactory receptor choice.
Peyer's patch-specific Lactobacillus reuteri strains increase extracellular microbial DNA and antimicrobial peptide expression in the mouse small intestine.
Determinants for clinical diagnosis of hypertrophic cardiomyopathy.
See All 28 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Determinants for clinical diagnosis of hypertrophic cardiomyopathy.
Adabag AS, Kuskowski MA, Maron BJ. Determinants for clinical diagnosis of hypertrophic cardiomyopathy. Am J Cardiol. 2006 Dec 01; 98(11):1507-11.
View in:
PubMed
subject areas
Adult
Cardiomyopathy, Hypertrophic
Death, Sudden, Cardiac
Echocardiography
Female
Humans
Male
Mass Screening
Middle Aged
Sports
authors with profiles
Barry J Maron MD